Abbott Laboratories
NYSE:ABT

  • LAST PRICE
    108.5200
  • TODAY'S CHANGE (%)
    -1.3600 (-1.2377%)
  • Bid / Lots
    108.5200/ 1
  • Ask / Lots
    108.5500/ 1
  • Open / Previous Close
    109.4000 / 109.8800
  • Day Range
    107.8100
    109.6550
  • 52 Week Range
    104.6300
    142.6000
  • Volume
    2,550,533

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Medical Equipment, Supplies & Distribution Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
ABT
Abbott Laboratories
185.3B
25.1x
+40.70%
MDT
Medtronic PLC
135.0B
28.5x
+0.82%
SYK
Stryker Corp
85.7B
44.3x
+3.69%
BDX
Becton Dickinson and Co
71.0B
39.5x
+8.84%
BAX
Baxter International Inc
36.3B
35.3x
-22.45%
DXCM
Dexcom Inc
30.9B
162.0x
---
As of 2022-05-16

Company Information

Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its Established Pharmaceutical Products segment includes gastroenterology products, women’s health products, cardiovascular and metabolic products, pain and central nervous system products and respiratory drugs and vaccines. Its Diagnostic Products segment includes core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion medicine; molecular diagnostics polymerase chain reaction (PCR) instrument systems; point of care systems; rapid diagnostics lateral flow testing products, and informatics and automation solutions. Its Nutritional Products segment includes various forms of infant formula and follow-on formula, adult and other pediatric nutritional products and others.

Contact Information

Headquarters
100 Abbott Park RdABBOTT PARK, IL, United States 60064-3500
Phone
224-667-6100
Fax
---

Executives

Chairman of the Board, Chief Executive Officer
Robert Ford
Chief Financial Officer, Executive Vice President - Finance
Robert Funck
Executive Vice President, General Counsel, Secretary
Hubert Allen
Executive Vice President - Human Resources
Mary Moreland
Executive Vice President - Ventures
John Capek

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$185.3B
Revenue (TTM)
$44.5B
Shares Outstanding
1.8B
Dividend Yield
1.73%
Annual Dividend Rate
1.8800 USD
Ex-Dividend Date
04-13-22
Pay Date
05-16-22
Beta
0.74
EPS
$4.33
Book Value
$20.29
P/E Ratio
25.1x
Price/Sales (TTM)
4.2
Price/Cash Flow (TTM)
16.6x
Operating Margin
20.73%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.